Home › Encyclopedia › GHRP-1 Peptide: Research Status and Clinical Trial Data
Research / Unapproved

GHRP-1 Peptide: Research Status and Clinical Trial Data

Drafted by an automated content engine from FDA, PubChem, ClinicalTrials.gov, NIH DSLD, and Open Beauty Facts data.

Molecular formulaC51H62N12O7
Molecular weight955.1 g/mol
Registered trials1
PubChem CID10350910

What GHRP-1 Is

GHRP-1 is a synthetic peptide compound identified by PubChem CID 10350910, with a molecular formula of C51H62N12O7 and a molecular weight of approximately 955.1 g/mol. It has no FDA-approved label, no approved brand name, and no assigned RxNorm identifier, meaning it is not authorized for any medical use in humans. GHRP-1 remains a research compound rather than a marketed drug.

Clinical Trial Footprint

One trial involving GHRP-1 is registered in the available data. That study, NCT00381602, was a Phase II, randomized, cross-over, vehicle-controlled, double-blind, multicenter trial examining safety, pharmacodynamics, and preliminary efficacy of GHRP-1/AG in subjects with end-stage renal disease on hemodialysis. This trial's status is listed as terminated. No additional trials or outcome data are available in the provided dataset.

FAQ

Is GHRP-1 approved by the FDA?
No. GHRP-1 has no FDA-approved label, no approved indication, and no approved brand name. It is classified as an unapproved research compound.
What is GHRP-1 chemically?
GHRP-1 is a synthetic peptide with the molecular formula C51H62N12O7 and a molecular weight of about 955.1 g/mol. It is catalogued in PubChem under CID 10350910.
Has GHRP-1 been studied in clinical trials?
One registered trial involving GHRP-1 has been identified. It was a Phase II study in hemodialysis patients with end-stage renal disease, and its status is listed as terminated.
What happened to the GHRP-1 trial in kidney disease patients?
The trial, NCT00381602, was a randomized, cross-over, double-blind study designed to assess safety, pharmacodynamics, and preliminary efficacy. The available data indicates the trial was terminated, with no further outcome details provided.
Are there known side effects of GHRP-1 in humans?
No side effect or adverse event data is available in the current dataset for GHRP-1. This reflects the limited clinical research record rather than a confirmed safety profile.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem CID 10350910 ClinicalTrials.gov NCT00381602

Updated 2026-08-10